Larvol Cliniclarvol.hashnode.devยทAug 8, 2024Hypofractionated Radiotherapy with Temozolomide and Bevacizumab in Glioblastoma: Phase II Trial ResultsPurpose: Bevacizumab is associated with decreased vascular permeability that allows for more aggressive radiotherapy schedules. We conducted a phase II trial in newly diagnosed glioblastoma utilizing a novel hypofractionated stereotactic radiotherapy...breast cancerAdd a thoughtful commentNo comments yetBe the first to start the conversation.
